562 related articles for article (PubMed ID: 23293059)
1. Stem cell models for drug discovery and toxicology studies.
Liu W; Deng Y; Liu Y; Gong W; Deng W
J Biochem Mol Toxicol; 2013 Jan; 27(1):17-27. PubMed ID: 23293059
[TBL] [Abstract][Full Text] [Related]
2. Human pluripotent stem cells in drug discovery and predictive toxicology.
Laustriat D; Gide J; Peschanski M
Biochem Soc Trans; 2010 Aug; 38(4):1051-7. PubMed ID: 20659002
[TBL] [Abstract][Full Text] [Related]
3. Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity.
Kuske B; Pulyanina PY; zur Nieden NI
Methods Mol Biol; 2012; 889():147-79. PubMed ID: 22669664
[TBL] [Abstract][Full Text] [Related]
4. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment.
Trosko JE; Chang CC
Toxicology; 2010 Mar; 270(1):18-34. PubMed ID: 19948204
[TBL] [Abstract][Full Text] [Related]
5. The application of human embryonic stem cell technologies to drug discovery.
Sartipy P; Björquist P; Strehl R; Hyllner J
Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
[TBL] [Abstract][Full Text] [Related]
6. Concise review: Human pluripotent stem cell-based models for cardiac and hepatic toxicity assessment.
Sartipy P; Björquist P
Stem Cells; 2011 May; 29(5):744-8. PubMed ID: 21433222
[TBL] [Abstract][Full Text] [Related]
7. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
8. Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening.
Palmer JA; Smith AM; Egnash LA; Conard KR; West PR; Burrier RE; Donley EL; Kirchner FR
Birth Defects Res B Dev Reprod Toxicol; 2013 Aug; 98(4):343-63. PubMed ID: 24123775
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
Jozefczuk J; Prigione A; Chavez L; Adjaye J
Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
[TBL] [Abstract][Full Text] [Related]
10. Human induced pluripotent stem cells and their use in drug discovery for toxicity testing.
Scott CW; Peters MF; Dragan YP
Toxicol Lett; 2013 May; 219(1):49-58. PubMed ID: 23470867
[TBL] [Abstract][Full Text] [Related]
11. Protein biomarkers for in vitro testing of toxicology.
Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K
Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942
[TBL] [Abstract][Full Text] [Related]
12. Human pluripotent stem cells for disease modelling and drug screening.
Maury Y; Gauthier M; Peschanski M; Martinat C
Bioessays; 2012 Jan; 34(1):61-71. PubMed ID: 22038777
[TBL] [Abstract][Full Text] [Related]
13. Pluripotent human stem cells as novel tools in drug discovery and toxicity testing.
Sartipy P; Bjorquist P; Strehl R; Hyllner J
IDrugs; 2006 Oct; 9(10):702-5. PubMed ID: 17016777
[TBL] [Abstract][Full Text] [Related]
14. Labeled stem cells as disease models and in drug discovery.
Ellerström C; Strehl R; Hyllner J
Methods Mol Biol; 2013; 997():239-51. PubMed ID: 23546761
[TBL] [Abstract][Full Text] [Related]
15. Can stem-cell-derived models revolutionize drug discovery?
Landgren H; Sartipy P
Expert Opin Drug Discov; 2014 Jan; 9(1):9-13. PubMed ID: 24308376
[TBL] [Abstract][Full Text] [Related]
16. Use and application of stem cells in toxicology.
Davila JC; Cezar GG; Thiede M; Strom S; Miki T; Trosko J
Toxicol Sci; 2004 Jun; 79(2):214-23. PubMed ID: 15014205
[TBL] [Abstract][Full Text] [Related]
17. Developmental toxicity testing for safety assessment: new approaches and technologies.
Knudsen TB; Kavlock RJ; Daston GP; Stedman D; Hixon M; Kim JH
Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):413-20. PubMed ID: 21770025
[TBL] [Abstract][Full Text] [Related]
18. The embryonic stem cell test combined with toxicogenomics as an alternative testing model for the assessment of developmental toxicity.
van Dartel DA; Piersma AH
Reprod Toxicol; 2011 Sep; 32(2):235-44. PubMed ID: 21575713
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
Song M; Paul S; Lim H; Dayem AA; Cho SG
Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
[TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cell proliferation and differentiation as parameters to evaluate developmental toxicity.
Pal R; Mamidi MK; Das AK; Bhonde R
J Cell Physiol; 2011 Jun; 226(6):1583-95. PubMed ID: 20945368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
